Bhatt Deepak Kumar, Gaedigk Andrea, Pearce Robin E, Leeder J Steven, Prasad Bhagwat
Department of Pharmaceutics, University of Washington, Seattle, Washington (D.K.B., B.P.); Department of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy-Kansas City, Missouri and School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri (A.G., R.E.P., J.S.L.).
Department of Pharmaceutics, University of Washington, Seattle, Washington (D.K.B., B.P.); Department of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy-Kansas City, Missouri and School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri (A.G., R.E.P., J.S.L.)
Drug Metab Dispos. 2017 Sep;45(9):1044-1048. doi: 10.1124/dmd.117.076463. Epub 2017 Jun 12.
Hepatic cytosolic alcohol and aldehyde dehydrogenases (ADHs and ALDHs) catalyze the biotransformation of xenobiotics (e.g., cyclophosphamide and ethanol) and vitamin A. Because age-dependent hepatic abundance of these proteins is unknown, we quantified protein expression of ADHs and ALDH1A1 in a large cohort of pediatric and adult human livers by liquid chromatography coupled with tandem mass spectrometry proteomics. Purified proteins were used as calibrators. Two to three surrogate peptides per protein were quantified in trypsin digests of liver cytosolic samples and calibrator proteins under optimal conditions of reproducibility. Neonatal levels of ADH1A, ADH1B, ADH1C, and ALDH1A1 were 3-, 8-, 146-, and 3-fold lower than the adult levels, respectively. For all proteins, the abundance steeply increased during the first year of life, which mostly reached adult levels during early childhood (age between 1 and 6 years). Only for ADH1A protein abundance in adults (age > 18 year) was ∼40% lower relative to the early childhood group. Abundances of ADHs and ALDH1A1 were not associated with sex in samples with age > 1 year compared with males. Known single nucleotide polymorphisms had no effect on the protein levels of these proteins. Quantification of ADHs and ALDH1A1 protein levels could be useful in predicting disposition and response of substrates of these enzymes in younger children.
肝细胞质中的乙醇脱氢酶和乙醛脱氢酶(ADHs和ALDHs)催化外源性物质(如环磷酰胺和乙醇)以及维生素A的生物转化。由于这些蛋白质在肝脏中的丰度随年龄的变化情况尚不清楚,我们通过液相色谱-串联质谱蛋白质组学技术,对大量儿童和成人肝脏样本中ADHs和ALDH1A1的蛋白质表达进行了定量分析。使用纯化的蛋白质作为校准物。在可重复性的最佳条件下,对肝脏细胞质样品和校准物蛋白质的胰蛋白酶消化产物中每种蛋白质的两到三个替代肽进行定量。新生儿期ADH1A、ADH1B、ADH1C和ALDH1A1的水平分别比成人水平低3倍、8倍、146倍和3倍。对于所有蛋白质,其丰度在生命的第一年急剧增加,在幼儿期(1至6岁)大多达到成人水平。仅成人(年龄>18岁)的ADH1A蛋白质丰度相对于幼儿组降低了约40%。与男性相比,年龄>1岁的样本中,ADHs和ALDH1A1的丰度与性别无关。已知的单核苷酸多态性对这些蛋白质的水平没有影响。ADHs和ALDH1A1蛋白质水平的定量分析可能有助于预测年幼儿童中这些酶底物的处置和反应情况。